Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice
Aryl hydrocarbon receptor (AhR) activation by high-affinity ligands mediates immunosuppression in association with increased regulatory T cells (Tregs), making this transcription factor an attractive therapeutic target for autoimmune diseases. We recently discovered 10-chloro-7H-benzimidazo[2,1-a]be...
Gespeichert in:
Veröffentlicht in: | The Journal of immunology (1950) 2016-01, Vol.196 (1), p.264-273 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 273 |
---|---|
container_issue | 1 |
container_start_page | 264 |
container_title | The Journal of immunology (1950) |
container_volume | 196 |
creator | Ehrlich, Allison K Pennington, Jamie M Wang, Xisheng Rohlman, Diana Punj, Sumit Löhr, Christiane V Newman, Matthew T Kolluri, Siva K Kerkvliet, Nancy I |
description | Aryl hydrocarbon receptor (AhR) activation by high-affinity ligands mediates immunosuppression in association with increased regulatory T cells (Tregs), making this transcription factor an attractive therapeutic target for autoimmune diseases. We recently discovered 10-chloro-7H-benzimidazo[2,1-a]benzo[de]iso-quinolin-7-one (10-Cl-BBQ), a nanomolar affinity AhR ligand with immunosuppressive activity and favorable pharmacologic properties. In this study, we tested the consequences of AhR activation in the NOD model. Oral 10-Cl-BBQ treatment prevented islet infiltration without clinical toxicity, whereas AhR-deficient NOD mice were not protected. Suppression of insulitis was associated with an increased frequency, but not total number, of Foxp3(+) Tregs in the pancreas and pancreatic lymph nodes. The requirement for Foxp3(+) cells in AhR-induced suppression of insulitis was tested using NOD.Foxp3(DTR) mice, which show extensive islet infiltration upon treatment with diphtheria toxin. AhR activation prevented the development of insulitis caused by the depletion of Foxp3(+) cells, demonstrating that Foxp3(+) cells are not required for AhR-mediated suppression and furthermore that the AhR pathway is able to compensate for the absence of Foxp3(+) Tregs, countering current dogma. Concurrently, the development of disease-associated CD4(+)Nrp1(+)Foxp3(-)RORγt(+) cells was inhibited by AhR activation. Taken together, 10-Cl-BBQ is an effective, nontoxic AhR ligand for the intervention of immune-mediated diseases that functions independently of Foxp3(+) Tregs to suppress pathogenic T cell development. |
doi_str_mv | 10.4049/jimmunol.1501789 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808683378</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1750437054</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2899-9bf641397ca54ffcf74629a94bb18f53f3614e035f76ba7bea91f349d30abbef3</originalsourceid><addsrcrecordid>eNqFkUtv1TAQhSMEopfCnhXyEgml2PErXt7ePqXyVFlHtjMGV04c7KQi_4qfWF_1li2bGWn0nXNGOlX1luAThpn6eOeHYRljOCEcE9mqZ9WGcI5rIbB4Xm0wbpqaSCGPqlc532GMBW7Yy-qoEVzSlvJN9XdrZ3-vZx9HFB2afwHapjWgq7VP0epkyv07WJjmmJBZEcH1LtSnp9_Q1wT3MM4ZXY95CX72GemxR-fOgd3Dt2gHIaCzQoU4DQUtZA8TlDHOYd3HXcQ_E_1QAn4uQRfRelBl5Ef0OY7RQAZ05rWB2Vv0yVt4Xb1wOmR4c9jH1Y-L89vdVX3z5fJ6t72pbdMqVSvjBCNUSas5c846yUSjtGLGkNZx6qggDDDlTgqjpQGtiKNM9RRrY8DR4-r9o--U4u8F8twNPtvymx4hLrkjLW5FS6ls_49KjhmVmLOC4kfUpphzAtdNyQ86rR3B3b7S7qnS7lBpkbw7uC9mgP6f4KlD-gDfeJ_y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1750437054</pqid></control><display><type>article</type><title>Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Ehrlich, Allison K ; Pennington, Jamie M ; Wang, Xisheng ; Rohlman, Diana ; Punj, Sumit ; Löhr, Christiane V ; Newman, Matthew T ; Kolluri, Siva K ; Kerkvliet, Nancy I</creator><creatorcontrib>Ehrlich, Allison K ; Pennington, Jamie M ; Wang, Xisheng ; Rohlman, Diana ; Punj, Sumit ; Löhr, Christiane V ; Newman, Matthew T ; Kolluri, Siva K ; Kerkvliet, Nancy I</creatorcontrib><description>Aryl hydrocarbon receptor (AhR) activation by high-affinity ligands mediates immunosuppression in association with increased regulatory T cells (Tregs), making this transcription factor an attractive therapeutic target for autoimmune diseases. We recently discovered 10-chloro-7H-benzimidazo[2,1-a]benzo[de]iso-quinolin-7-one (10-Cl-BBQ), a nanomolar affinity AhR ligand with immunosuppressive activity and favorable pharmacologic properties. In this study, we tested the consequences of AhR activation in the NOD model. Oral 10-Cl-BBQ treatment prevented islet infiltration without clinical toxicity, whereas AhR-deficient NOD mice were not protected. Suppression of insulitis was associated with an increased frequency, but not total number, of Foxp3(+) Tregs in the pancreas and pancreatic lymph nodes. The requirement for Foxp3(+) cells in AhR-induced suppression of insulitis was tested using NOD.Foxp3(DTR) mice, which show extensive islet infiltration upon treatment with diphtheria toxin. AhR activation prevented the development of insulitis caused by the depletion of Foxp3(+) cells, demonstrating that Foxp3(+) cells are not required for AhR-mediated suppression and furthermore that the AhR pathway is able to compensate for the absence of Foxp3(+) Tregs, countering current dogma. Concurrently, the development of disease-associated CD4(+)Nrp1(+)Foxp3(-)RORγt(+) cells was inhibited by AhR activation. Taken together, 10-Cl-BBQ is an effective, nontoxic AhR ligand for the intervention of immune-mediated diseases that functions independently of Foxp3(+) Tregs to suppress pathogenic T cell development.</description><identifier>ISSN: 0022-1767</identifier><identifier>ISSN: 1550-6606</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.1501789</identifier><identifier>PMID: 26573835</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Benzimidazoles - administration & dosage ; Benzimidazoles - pharmacology ; Diabetes Mellitus, Type 1 - prevention & control ; Enzyme Activation ; Forkhead Transcription Factors - metabolism ; Immunosuppressive Agents - administration & dosage ; Immunosuppressive Agents - pharmacology ; Inflammation - prevention & control ; Islets of Langerhans - drug effects ; Islets of Langerhans - immunology ; Isoquinolines - administration & dosage ; Isoquinolines - pharmacology ; Lymph Nodes - cytology ; Lymph Nodes - immunology ; Mice ; Mice, Inbred C57BL ; Mice, Inbred NOD ; Receptors, Aryl Hydrocarbon - agonists ; Th1 Cells - immunology ; Th17 Cells - immunology</subject><ispartof>The Journal of immunology (1950), 2016-01, Vol.196 (1), p.264-273</ispartof><rights>Copyright © 2015 by The American Association of Immunologists, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2899-9bf641397ca54ffcf74629a94bb18f53f3614e035f76ba7bea91f349d30abbef3</citedby><cites>FETCH-LOGICAL-c2899-9bf641397ca54ffcf74629a94bb18f53f3614e035f76ba7bea91f349d30abbef3</cites><orcidid>0000-0002-3982-0327 ; 0000-0003-3787-5583</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26573835$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ehrlich, Allison K</creatorcontrib><creatorcontrib>Pennington, Jamie M</creatorcontrib><creatorcontrib>Wang, Xisheng</creatorcontrib><creatorcontrib>Rohlman, Diana</creatorcontrib><creatorcontrib>Punj, Sumit</creatorcontrib><creatorcontrib>Löhr, Christiane V</creatorcontrib><creatorcontrib>Newman, Matthew T</creatorcontrib><creatorcontrib>Kolluri, Siva K</creatorcontrib><creatorcontrib>Kerkvliet, Nancy I</creatorcontrib><title>Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>Aryl hydrocarbon receptor (AhR) activation by high-affinity ligands mediates immunosuppression in association with increased regulatory T cells (Tregs), making this transcription factor an attractive therapeutic target for autoimmune diseases. We recently discovered 10-chloro-7H-benzimidazo[2,1-a]benzo[de]iso-quinolin-7-one (10-Cl-BBQ), a nanomolar affinity AhR ligand with immunosuppressive activity and favorable pharmacologic properties. In this study, we tested the consequences of AhR activation in the NOD model. Oral 10-Cl-BBQ treatment prevented islet infiltration without clinical toxicity, whereas AhR-deficient NOD mice were not protected. Suppression of insulitis was associated with an increased frequency, but not total number, of Foxp3(+) Tregs in the pancreas and pancreatic lymph nodes. The requirement for Foxp3(+) cells in AhR-induced suppression of insulitis was tested using NOD.Foxp3(DTR) mice, which show extensive islet infiltration upon treatment with diphtheria toxin. AhR activation prevented the development of insulitis caused by the depletion of Foxp3(+) cells, demonstrating that Foxp3(+) cells are not required for AhR-mediated suppression and furthermore that the AhR pathway is able to compensate for the absence of Foxp3(+) Tregs, countering current dogma. Concurrently, the development of disease-associated CD4(+)Nrp1(+)Foxp3(-)RORγt(+) cells was inhibited by AhR activation. Taken together, 10-Cl-BBQ is an effective, nontoxic AhR ligand for the intervention of immune-mediated diseases that functions independently of Foxp3(+) Tregs to suppress pathogenic T cell development.</description><subject>Animals</subject><subject>Benzimidazoles - administration & dosage</subject><subject>Benzimidazoles - pharmacology</subject><subject>Diabetes Mellitus, Type 1 - prevention & control</subject><subject>Enzyme Activation</subject><subject>Forkhead Transcription Factors - metabolism</subject><subject>Immunosuppressive Agents - administration & dosage</subject><subject>Immunosuppressive Agents - pharmacology</subject><subject>Inflammation - prevention & control</subject><subject>Islets of Langerhans - drug effects</subject><subject>Islets of Langerhans - immunology</subject><subject>Isoquinolines - administration & dosage</subject><subject>Isoquinolines - pharmacology</subject><subject>Lymph Nodes - cytology</subject><subject>Lymph Nodes - immunology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Inbred NOD</subject><subject>Receptors, Aryl Hydrocarbon - agonists</subject><subject>Th1 Cells - immunology</subject><subject>Th17 Cells - immunology</subject><issn>0022-1767</issn><issn>1550-6606</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtv1TAQhSMEopfCnhXyEgml2PErXt7ePqXyVFlHtjMGV04c7KQi_4qfWF_1li2bGWn0nXNGOlX1luAThpn6eOeHYRljOCEcE9mqZ9WGcI5rIbB4Xm0wbpqaSCGPqlc532GMBW7Yy-qoEVzSlvJN9XdrZ3-vZx9HFB2afwHapjWgq7VP0epkyv07WJjmmJBZEcH1LtSnp9_Q1wT3MM4ZXY95CX72GemxR-fOgd3Dt2gHIaCzQoU4DQUtZA8TlDHOYd3HXcQ_E_1QAn4uQRfRelBl5Ef0OY7RQAZ05rWB2Vv0yVt4Xb1wOmR4c9jH1Y-L89vdVX3z5fJ6t72pbdMqVSvjBCNUSas5c846yUSjtGLGkNZx6qggDDDlTgqjpQGtiKNM9RRrY8DR4-r9o--U4u8F8twNPtvymx4hLrkjLW5FS6ls_49KjhmVmLOC4kfUpphzAtdNyQ86rR3B3b7S7qnS7lBpkbw7uC9mgP6f4KlD-gDfeJ_y</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Ehrlich, Allison K</creator><creator>Pennington, Jamie M</creator><creator>Wang, Xisheng</creator><creator>Rohlman, Diana</creator><creator>Punj, Sumit</creator><creator>Löhr, Christiane V</creator><creator>Newman, Matthew T</creator><creator>Kolluri, Siva K</creator><creator>Kerkvliet, Nancy I</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope><orcidid>https://orcid.org/0000-0002-3982-0327</orcidid><orcidid>https://orcid.org/0000-0003-3787-5583</orcidid></search><sort><creationdate>20160101</creationdate><title>Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice</title><author>Ehrlich, Allison K ; Pennington, Jamie M ; Wang, Xisheng ; Rohlman, Diana ; Punj, Sumit ; Löhr, Christiane V ; Newman, Matthew T ; Kolluri, Siva K ; Kerkvliet, Nancy I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2899-9bf641397ca54ffcf74629a94bb18f53f3614e035f76ba7bea91f349d30abbef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Benzimidazoles - administration & dosage</topic><topic>Benzimidazoles - pharmacology</topic><topic>Diabetes Mellitus, Type 1 - prevention & control</topic><topic>Enzyme Activation</topic><topic>Forkhead Transcription Factors - metabolism</topic><topic>Immunosuppressive Agents - administration & dosage</topic><topic>Immunosuppressive Agents - pharmacology</topic><topic>Inflammation - prevention & control</topic><topic>Islets of Langerhans - drug effects</topic><topic>Islets of Langerhans - immunology</topic><topic>Isoquinolines - administration & dosage</topic><topic>Isoquinolines - pharmacology</topic><topic>Lymph Nodes - cytology</topic><topic>Lymph Nodes - immunology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Inbred NOD</topic><topic>Receptors, Aryl Hydrocarbon - agonists</topic><topic>Th1 Cells - immunology</topic><topic>Th17 Cells - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ehrlich, Allison K</creatorcontrib><creatorcontrib>Pennington, Jamie M</creatorcontrib><creatorcontrib>Wang, Xisheng</creatorcontrib><creatorcontrib>Rohlman, Diana</creatorcontrib><creatorcontrib>Punj, Sumit</creatorcontrib><creatorcontrib>Löhr, Christiane V</creatorcontrib><creatorcontrib>Newman, Matthew T</creatorcontrib><creatorcontrib>Kolluri, Siva K</creatorcontrib><creatorcontrib>Kerkvliet, Nancy I</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ehrlich, Allison K</au><au>Pennington, Jamie M</au><au>Wang, Xisheng</au><au>Rohlman, Diana</au><au>Punj, Sumit</au><au>Löhr, Christiane V</au><au>Newman, Matthew T</au><au>Kolluri, Siva K</au><au>Kerkvliet, Nancy I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>196</volume><issue>1</issue><spage>264</spage><epage>273</epage><pages>264-273</pages><issn>0022-1767</issn><issn>1550-6606</issn><eissn>1550-6606</eissn><abstract>Aryl hydrocarbon receptor (AhR) activation by high-affinity ligands mediates immunosuppression in association with increased regulatory T cells (Tregs), making this transcription factor an attractive therapeutic target for autoimmune diseases. We recently discovered 10-chloro-7H-benzimidazo[2,1-a]benzo[de]iso-quinolin-7-one (10-Cl-BBQ), a nanomolar affinity AhR ligand with immunosuppressive activity and favorable pharmacologic properties. In this study, we tested the consequences of AhR activation in the NOD model. Oral 10-Cl-BBQ treatment prevented islet infiltration without clinical toxicity, whereas AhR-deficient NOD mice were not protected. Suppression of insulitis was associated with an increased frequency, but not total number, of Foxp3(+) Tregs in the pancreas and pancreatic lymph nodes. The requirement for Foxp3(+) cells in AhR-induced suppression of insulitis was tested using NOD.Foxp3(DTR) mice, which show extensive islet infiltration upon treatment with diphtheria toxin. AhR activation prevented the development of insulitis caused by the depletion of Foxp3(+) cells, demonstrating that Foxp3(+) cells are not required for AhR-mediated suppression and furthermore that the AhR pathway is able to compensate for the absence of Foxp3(+) Tregs, countering current dogma. Concurrently, the development of disease-associated CD4(+)Nrp1(+)Foxp3(-)RORγt(+) cells was inhibited by AhR activation. Taken together, 10-Cl-BBQ is an effective, nontoxic AhR ligand for the intervention of immune-mediated diseases that functions independently of Foxp3(+) Tregs to suppress pathogenic T cell development.</abstract><cop>United States</cop><pmid>26573835</pmid><doi>10.4049/jimmunol.1501789</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-3982-0327</orcidid><orcidid>https://orcid.org/0000-0003-3787-5583</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1767 |
ispartof | The Journal of immunology (1950), 2016-01, Vol.196 (1), p.264-273 |
issn | 0022-1767 1550-6606 1550-6606 |
language | eng |
recordid | cdi_proquest_miscellaneous_1808683378 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Animals Benzimidazoles - administration & dosage Benzimidazoles - pharmacology Diabetes Mellitus, Type 1 - prevention & control Enzyme Activation Forkhead Transcription Factors - metabolism Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - pharmacology Inflammation - prevention & control Islets of Langerhans - drug effects Islets of Langerhans - immunology Isoquinolines - administration & dosage Isoquinolines - pharmacology Lymph Nodes - cytology Lymph Nodes - immunology Mice Mice, Inbred C57BL Mice, Inbred NOD Receptors, Aryl Hydrocarbon - agonists Th1 Cells - immunology Th17 Cells - immunology |
title | Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T18%3A31%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20the%20Aryl%20Hydrocarbon%20Receptor%20by%2010-Cl-BBQ%20Prevents%20Insulitis%20and%20Effector%20T%20Cell%20Development%20Independently%20of%20Foxp3+%20Regulatory%20T%20Cells%20in%20Nonobese%20Diabetic%20Mice&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Ehrlich,%20Allison%20K&rft.date=2016-01-01&rft.volume=196&rft.issue=1&rft.spage=264&rft.epage=273&rft.pages=264-273&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.1501789&rft_dat=%3Cproquest_cross%3E1750437054%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1750437054&rft_id=info:pmid/26573835&rfr_iscdi=true |